← Open Payments lookup

KONSTANTIN TETELMAN: Open Payments

NPI 1447836457 · FORT WASHINGTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$416 in 9 payments from 6 companies in 2025. Trend: 2023 $234 · 2024 $664 · 2025 $416

Food & beverage: $416
CompanyPaymentsAmount
Alkermes, Inc.2$138
E.R. Squibb & Sons, L.L.C.1$121
Otsuka America Pharmaceutical, Inc.2$55
Janssen Pharmaceuticals, Inc2$51
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$28
Luye Pharma (USA) Ltd.1$22

Products named: ARISTADA, COBENFY, ABILIFY ASIMTUFII, CAPLYTA, INVEGA SUSTENNA, SPRAVATO, ERZOFRI EXTENDED-RELEASE.

Industry payments across PA — which companies pay providers there.